Seminars in Pediatric Neurology
Volume 13, Issue 1 , Pages 2-7, March 2006

Clinical Manifestations and Management of Neurofibromatosis Type 1

  • James H. Tonsgard, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to James H. Tonsgard, MD, Departments of Pediatrics and Neurology, University of Chicago Hospitals, 5841 S Maryland Avenue, MC 3055, Chicago, IL 60637.

Departments of Pediatrics and Neurology, Pritzker School of Medicine, The University of Chicago, Chicago, IL

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with variable expression. The complications are age specific. Neurologic complications include tumors of the peripheral nerves, nerve roots, and plexi; spinal cord compression; dural ectasias; learning disabilities; attention deficit; headaches; seizures; brain tumors; deafness; hydrocephalus; and stroke. High-intensity signals on brain magnetic resonance imaging are a frequent finding without known clinical significance. Most brain tumors are benign and asymptomatic, but malignant brain tumors occur. The major cause of death is malignancy, including brain tumors and malignant peripheral nerve sheath tumors. Management includes genetic counseling, regular eye examinations, and careful physical exams.

Keywords:  neurofibromatosis type 1 , NF1 , neurofibromas , learning disabilities , peripheral nerve tumors , brain tumors

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a grant from Illinois Neurofibromatosis, Inc. and a grant from the US Army Medical Research and Materiel Command, contract W81XWH-06-1-0026.

PII: S1071-9091(06)00009-X

doi:10.1016/j.spen.2006.01.005

Seminars in Pediatric Neurology
Volume 13, Issue 1 , Pages 2-7, March 2006